Literature DB >> 7088857

Faecal occult blood testing for colorectal cancer in general practice.

R Million, J Howarth, E Turnberg, L A Turnberg.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 7088857

Source DB:  PubMed          Journal:  Practitioner        ISSN： 0032-6518


× No keyword cloud information.
  10 in total

1.  The effect on compliance of a health education leaflet in colorectal cancer screening in general practice in central England.

Authors:  A R Hart; T L Barone; S P Gay; A Inglis; L Griffin; C A Tallon; J F Mayberry
Journal:  J Epidemiol Community Health       Date:  1997-04       Impact factor: 3.710

2.  Colorectal cancer prevention. An approach to increasing compliance in a faecal occult blood test screening programme.

Authors:  A R Hart; J Eaden; S Barnett; A M de Bono; J F Mayberry
Journal:  J Epidemiol Community Health       Date:  1998-12       Impact factor: 3.710

Review 3.  Early diagnosis of colorectal cancer: a review.

Authors:  J D Hardcastle; N C Armitage
Journal:  J R Soc Med       Date:  1984-08       Impact factor: 5.344

Review 4.  The pros and cons of fecal occult blood testing for colorectal neoplasms.

Authors:  J B Simon
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 5.  Colorectal carcinoma and Haemoccult. A study of its value in mass screening using meta-analysis.

Authors:  J Windeler; J Köbberling
Journal:  Int J Colorectal Dis       Date:  1987-11       Impact factor: 2.571

6.  Screening for colorectal cancer: reasons for refusal of faecal occult blood testing in a general practice in England.

Authors:  K A Hynam; A R Hart; S P Gay; A Inglis; A C Wicks; J F Mayberry
Journal:  J Epidemiol Community Health       Date:  1995-02       Impact factor: 3.710

7.  An industry based approach to colorectal cancer screening in an asymptomatic population.

Authors:  A R Hart; N Glover; J Howick-Baker; J F Mayberry
Journal:  Postgrad Med J       Date:  2003-11       Impact factor: 2.401

8.  The clinical value of Haemoccult and Fecatwin in the detection of colorectal neoplasia in hospital and general practice patients.

Authors:  I G Barrison; R A Parkins
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

9.  National industry's interest in colorectal cancer screening programmes.

Authors:  A R Hart; T L Barone; A C Wicks; J F Mayberry
Journal:  J R Soc Med       Date:  1994-11       Impact factor: 18.000

10.  Screening for colorectal cancer in a factory-based population with Fecatest.

Authors:  F I Lee
Journal:  Br J Cancer       Date:  1983-12       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.